Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly kno...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

WVU1 Oct. 25 at 12:31 AM

$NRXS This one got me bag holder for life

0 · Reply

Jaybird99 Oct. 24 at 11:51 PM

$NRXS right now is a strong entry point. FDA clearance is huge and a big deal... means device is complete and ready to be sold on the market. As per the release this is a unique first of a kind medical device. If promising this has the potential to make the company profitable to go back to 10 and really take off and stay there....it's just such a low float it can knife down a dollar any given day. Played $NERV a week ago when it went from $2 to 11. ...looking for a similar squeeze with nrxs in the coming week.

0 · Reply

Slab6 Oct. 24 at 11:02 PM

$NRXS at least take it under my 2.80 average so I can lower my average

0 · Reply

shinglenail Oct. 24 at 10:13 PM

$NRXS buy the rumor sell the news!

1 · Reply

shinglenail Oct. 24 at 8:54 PM

$NRXS it’s found it’s top pivot and bottom pivot all in one day😂

0 · Reply

Hoopbaby07 Oct. 24 at 8:29 PM

$NRXS the day trade rule is really “protecting “me right now 😂 wish they would get rid of that shit all together

2 · Reply

shinglenail Oct. 24 at 8:23 PM

$NRXS dropped almost a dollar in 5 minutes?

0 · Reply

WelshDragon75 Oct. 24 at 8:06 PM

$NRXS shorts selling to themselves or dark pools. Have fun shorts with that cover.

0 · Reply

WVU1 Oct. 24 at 8:04 PM

$NRXS WOW 😧

1 · Reply

_www_larval_com_ Oct. 24 at 7:57 PM

$PMI 9%[-59%] $JL -5%[-15%] $NRXS -4%[-10%] $ORBS 4%[-1%] $FORD 4%[-6%] most notable movement into the final minutes of trading.

0 · Reply

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

Jun 17, 2025, 8:00 AM EDT - 4 months ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

May 22, 2025, 1:03 PM EDT - 5 months ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 5 months ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 1:58 PM EDT - 5 months ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:15 AM EDT - 5 months ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 6 months ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Mar 20, 2025, 4:18 PM EDT - 7 months ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:15 AM EDT - 7 months ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 8 months ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Jan 21, 2025, 1:45 PM EST - 9 months ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 9 months ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 9:00 AM EST - 10 months ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 10 months ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Nov 15, 2024, 2:04 PM EST - 1 year ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 11, 2024, 5:44 AM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jun 7, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 1:34 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 6:45 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 4:05 PM EDT - 1 year ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 1, 2024, 4:15 PM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 1 year ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 1 year ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 1 year ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 13, 2023, 9:00 AM EDT - 2 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 2 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

Aug 15, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

Aug 12, 2023, 6:00 AM EDT - 2 years ago

U.S. IPO Weekly Recap: IPO Market Sees Fitness, Liquor Marketing, And Medical Devices

ANL FTEL NWGL VFS

WVU1 Oct. 25 at 12:31 AM

$NRXS This one got me bag holder for life

0 · Reply

Jaybird99 Oct. 24 at 11:51 PM

0 · Reply

Slab6 Oct. 24 at 11:02 PM

$NRXS at least take it under my 2.80 average so I can lower my average

0 · Reply

shinglenail Oct. 24 at 10:13 PM

$NRXS buy the rumor sell the news!

1 · Reply

shinglenail Oct. 24 at 8:54 PM

$NRXS it’s found it’s top pivot and bottom pivot all in one day😂

0 · Reply

Hoopbaby07 Oct. 24 at 8:29 PM

$NRXS the day trade rule is really “protecting “me right now 😂 wish they would get rid of that shit all together

2 · Reply

shinglenail Oct. 24 at 8:23 PM

$NRXS dropped almost a dollar in 5 minutes?

0 · Reply

WelshDragon75 Oct. 24 at 8:06 PM

$NRXS shorts selling to themselves or dark pools. Have fun shorts with that cover.

0 · Reply

WVU1 Oct. 24 at 8:04 PM

$NRXS WOW 😧

1 · Reply

_www_larval_com_ Oct. 24 at 7:57 PM

$PMI 9%[-59%] $JL -5%[-15%] $NRXS -4%[-10%] $ORBS 4%[-1%] $FORD 4%[-6%] most notable movement into the final minutes of trading.

0 · Reply

Jaybird99 Oct. 24 at 7:03 PM

$NRXS volume picking up first pt 4.0 than 4.4 vwap.

0 · Reply

marketmoney402 Oct. 24 at 7:00 PM

$NRXS haha ;)

0 · Reply

This_Guy_Nose_Stocks Oct. 24 at 6:54 PM

$GNTA $NEUP $NRXS $SPY $TOVX If that $TOVX float # is correct Next week will be very interesting

0 · Reply

PennySpot Oct. 24 at 6:51 PM

$TOVX hi everyone in this picture you will see at what hour we've detected this stock, we are so sorry to skip that one due to the score according by our algo ... but we catch it at 0.37 for 0.79 thats represent +113% !!!!! $NEUP $NRXS $GNTA $SPY free salary with me

1 · Reply

matthew122 Oct. 24 at 5:57 PM

$NRXS I think it will flip back to green. Who would sell on this incredible news?

1 · Reply

Jaybird99 Oct. 24 at 5:42 PM

$NRXS low float stock can easily hit 4 With potential squeeze to 5

0 · Reply

marketmoney402 Oct. 24 at 5:32 PM

$NRXS strong AH possibility

1 · Reply

charles2_01 Oct. 24 at 4:27 PM

$NRXS Increased ATM from $3.3M to $6.27M. Per filing company has not yet used this facility. So at present stock price company could issue about 1.9 million shares from time to time as needed....less if stock price increases. Access to more patients (adults) per today's filing (FDA approval) with no competition. CPT reimbursement starts 1/2026. To me there is a big upside particularly as 2026 approaches.

0 · Reply

Slab6 Oct. 24 at 4:14 PM

$NRXS this will climb back up gradually

0 · Reply

MrTicker Oct. 24 at 4:09 PM

$NRXS slow uptrend reversal on the 5 min. Break above 4 with some volume could get some scanner attention. pre-market high of $5.96 . It's possible we could test $5 during power

0 · Reply

trading_momentum_x Oct. 24 at 3:59 PM

$NRXS looks good to me here, this one is trying to break its downtrend with one big breakout candle with huge increase in volume. Let's see if we can get some actual follow through tho in coming days. Resistance at 3.8

0 · Reply

Neegud Oct. 24 at 3:59 PM

$BYND $NRXS $YYAI added $SCNX back at 1.52. Shall we go back to 2.5. Bynd Averaged to 2.7.

0 · Reply

Market Cap	37.71M
Revenue (ttm)	2.69M
Net Income (ttm)	-8.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-306.32%
Debt to Equity Ratio	0.00

Volume	18,560,600
Avg Vol	434,532
Day's Range	N/A - N/A
Shares Out	9.87M
Stochastic %K	58%
Beta	3.18
Analysts	Strong Sell
Price Target	$7.00